Venus Concept (VERO) Competitors $2.74 +0.10 (+3.58%) As of 02:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VERO vs. OSRH, STRR, AEMD, AMIX, NUWE, CHEK, SINT, CTCX, GCTK, and TNONShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include OSR (OSRH), Star Equity (STRR), Aethlon Medical (AEMD), Autonomix Medical (AMIX), Nuwellis (NUWE), Check-Cap (CHEK), Sintx Technologies (SINT), Carmell (CTCX), GlucoTrack (GCTK), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry. Venus Concept vs. OSR Star Equity Aethlon Medical Autonomix Medical Nuwellis Check-Cap Sintx Technologies Carmell GlucoTrack Tenon Medical OSR (NASDAQ:OSRH) and Venus Concept (NASDAQ:VERO) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Which has more volatility and risk, OSRH or VERO? OSR has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Does the MarketBeat Community believe in OSRH or VERO? Venus Concept received 34 more outperform votes than OSR when rated by MarketBeat users. CompanyUnderperformOutperformOSRN/AN/AVenus ConceptOutperform Votes3465.38% Underperform Votes1834.62% Is OSRH or VERO more profitable? OSR has a net margin of 0.00% compared to Venus Concept's net margin of -74.62%. Company Net Margins Return on Equity Return on Assets OSRN/A N/A N/A Venus Concept -74.62%N/A -47.46% Does the media refer more to OSRH or VERO? In the previous week, Venus Concept had 2 more articles in the media than OSR. MarketBeat recorded 3 mentions for Venus Concept and 1 mentions for OSR. OSR's average media sentiment score of 1.87 beat Venus Concept's score of 0.62 indicating that OSR is being referred to more favorably in the media. Company Overall Sentiment OSR Very Positive Venus Concept Positive Which has better valuation & earnings, OSRH or VERO? OSR has higher revenue and earnings than Venus Concept. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOSR$4.89B0.00N/AN/AN/AVenus Concept$67.20M0.03-$37.25M-$88.23-0.03 Do institutionals & insiders have more ownership in OSRH or VERO? 55.3% of OSR shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 33.7% of OSR shares are owned by company insiders. Comparatively, 49.0% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryOSR and Venus Concept tied by winning 5 of the 10 factors compared between the two stocks. Remove Ads Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.75M$4.38B$5.67B$8.12BDividend YieldN/A29.35%4.40%4.10%P/E Ratio-0.3328.9123.9019.07Price / Sales0.0351.78395.6188.24Price / CashN/A51.0838.1134.64Price / Book-1.096.106.834.29Net Income-$37.25M$67.64M$3.20B$247.56M7 Day Performance-3.99%0.74%8.77%2.11%1 Month Performance-27.37%-11.04%-0.35%-9.37%1 Year Performance-65.56%19.62%13.04%4.01% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept0.7632 of 5 stars$2.75+3.6%N/A-65.6%$1.81M$67.20M-0.34410OSRHOSRN/A$1.78-22.3%N/AN/A$7.19M$4.89B0.00N/APositive NewsSTRRStar Equity1.3888 of 5 stars$2.20-2.7%N/A-51.9%$7.08M$50.38M-0.86460AEMDAethlon Medical2.935 of 5 stars$0.41-5.5%$7.00+1,597.4%-78.4%$5.96M$570,000.00-0.2610Short Interest ↓AMIXAutonomix Medical3.5073 of 5 stars$2.37-10.6%$28.00+1,081.4%-97.0%$5.84MN/A-0.181Short Interest ↓Gap DownNUWENuwellis2.8491 of 5 stars$1.26-2.7%$17.00+1,249.2%-91.9%$5.51M$8.97M-0.0170Short Interest ↓CHEKCheck-Cap0.3109 of 5 stars$0.77-4.0%N/A-60.1%$4.51MN/A-0.2680Analyst ForecastShort Interest ↑Gap DownSINTSintx Technologies0.3278 of 5 stars$3.25-1.8%N/A-86.3%$4.37M$1.64M-0.0640Gap DownCTCXCarmell1.5372 of 5 stars$0.20+3.3%N/A-89.9%$4.20M$32,839.000.0014Gap DownGCTKGlucoTrack0.5829 of 5 stars$0.38+4.1%N/A-98.8%$4.00MN/A-0.015News CoverageHigh Trading VolumeTNONTenon Medical2.1709 of 5 stars$1.25-3.8%$5.50+340.0%-13.5%$3.92M$3.32M-0.058High Trading Volume Remove Ads Related Companies and Tools Related Companies OSRH Alternatives STRR Alternatives AEMD Alternatives AMIX Alternatives NUWE Alternatives CHEK Alternatives SINT Alternatives CTCX Alternatives GCTK Alternatives TNON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
